Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency
Oncology·MeSH: Mucopolysaccharidosis I
Prevalence
5.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency?
There are 2 clinical trials targeting Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency tracked by BioSniper.
What is the prevalence of Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency?
The estimated prevalence of Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency is approximately 5.0 per 100,000 population.
Deep-dive into Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis